Wire · opportunities
FDA Approves Blood-Based Test for Colorectal Cancer Screening
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 July 2026 · Fusion42 review
The FDA has approved a blood-based test for colorectal cancer screening, offering a non-invasive alternative to traditional colonoscopy-based approaches. This regulatory clearance opens a new market category for liquid biopsy diagnostics in cancer prevention.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it between 27 Jul 2026 and 5 Aug 2026.
◆ ◆ The Wire takeaway
Blood tests for colorectal cancer just became FDA-approved, which means insurers will now fund them and patients will choose them over colonoscopies. If you supply the lab automation, consumables, or data analysis software that runs these tests at scale, you have a customer in every diagnostic lab in America.
◆ Coverage
2 sources · first reported 27 Jul 2026 · latest 5 Aug 2026
◆ Related on Wire
◆ Topics